Logo

chemotherapy

Diacarta Positioning Liquid Biopsy Assay to Gauge Chemotherapy Response in Multiple Cancers
Premium

The firm has launched a validation trial for its in-development QuantiDNA cell-free DNA chemotherapy response assay in late-stage smoking-related cancers.

Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests

Myriad Genetics' EndoPredict, Agendia's MammaPrint (distributed in Germany by PathoNext), and Veracyte's Prosigna will now be covered by public insurance.

Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test

Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.

Israeli Startup Curesponse Targets European Pharma Market With Drug Prediction, Development Service
Premium

The firm's technology uses ex vivo organ culture to model cancer growth and predict a patient's tumor response to chemotherapy and targeted drugs. 

Veracyte's Prosigna IDs Breast Cancer Patients Likely to Benefit from Aggressive Chemotherapy

Patients with luminal breast cancer subtypes may do just as well without anthracycline-based chemo and avoid unnecessary toxicities, a study showed.

May 8, 2019

Almac Assay's Ability to Stratify Esophageal Cancer Patients Demonstrated by UK Researchers
Premium

Sep 17, 2018

NGS-Based Post-Transplant Acute Myeloid Leukemia Assay Predicts Relapse Risk
Premium

Jun 3, 2018

Fewer Breast Cancer Patients Benefit From Chemo, TAILORx Study With Oncotype DX Finds

Jan 12, 2017

German Report Sees No Benefit From Genomic Breast Cancer Tests for Chemo Decisions
Premium

Nov 21, 2016

Copy Number Profiles Classify Lung Cancer Patients as Sensitive or Resistant to Therapy

Apr 20, 2016

Burgeoning Radiogenomics Efforts Aim to Improve Cancer Therapy, Reduce Toxicities
Premium

Aug 27, 2015

In Medicare Population, Oncotype DX Linked to Less Chemo in High-Risk Patients, More in Low-Risk
Premium

Apr 13, 2015

Exploratory Study Provides Early Evidence for PGx Chemo Response Predictor in Osteosarcoma
Premium

Jan 25, 2012

Sequencing Study Suggests Potential New Treatments for ALL Subset with Poor Response
Premium

Jul 27, 2011

St. Gallen Experts Recommend Oncotype DX for Chemoprediction; Support Breast Cancer Subtyping
Premium

Dec 15, 2010

At SABCS, Presentations Highlight Ongoing Issues with Tamoxifen PGx
Premium

Apr 29, 2009

Genomic Health Could See Japanese Sales Efforts Buoyed by Positive Oncotype DX Trial
Premium

Apr 23, 2009

Cequent Releases Data on RNAi Technology for Multi-Gene Targeting, Addressing Cancer Drug Resistance
Premium

Apr 22, 2009

American Association for Cancer Research 2009 Annual Meeting PGx Abstracts
Premium

Apr 22, 2009

Tech Transfer Tidbits: Apr 22, 2009
Premium

Apr 17, 2009

DiaTech Licenses Vanderbilt's Personalized Tumor Test

Apr 15, 2009

Genomic Health's Colon Cancer Dx Meets Prognostic, Not Predictive, Endpoint; Will Debut in 2010
Premium

Apr 8, 2009

Snippets: Apr 8, 2009
Premium

Apr 8, 2009

Komen to Fund Cancer PGx Research through New Grants

Apr 7, 2009

BioArray Briefs: 2009.04.07
Premium

Breaking News
The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.